Home / Inspections / 1281041

FDA Inspection 1281041 — Centaur Pharmaceuticals Private Ltd.

Centaur Pharmaceuticals Private Ltd. — FEI 3003973520

The FDA completed an inspection of Centaur Pharmaceuticals Private Ltd. on July 25, 2025 in Thane. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 25, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Thane (India)

Facility

Other inspections at this facility

  • 1192256 (OAI Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1107995 (VAI Fri Sep 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 994501 (NAI Thu Oct 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 914387 (NAI Thu Feb 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 740701 (VAI Thu Aug 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources